English | Español

Arena Pharmaceuticals
Cheyenne Dickerson | May 21, 2017

Arena Pharmaceuticals preparing to present ralinepag drug Phase 1 results

Carol Ostrow | Feb 16, 2017

Arena presenting latest data on ulcerative colitis drug at summit
Carol Ostrow | Jan 13, 2017

Eisai acquires rights to Lorcaserin HCI for weight control
Jeff Gantt | Dec 24, 2016

ANVISA approves Belviq in Brazil
Carol Ostrow | Dec 16, 2016

Arena Pharmaceuticals plans Jan. 12 webcast, conference presentation

Jeff Gantt | Dec 14, 2016

Arena finalizes enrollment in ralinepag trial
Amanda Rupp | May 26, 2016

Arena Pharmaceuticals welcomes new president, CEO

Trending
+ Pharmaceuticals
Patient Daily | Sep 12, 2025

Taxpayers Protection Alliance says 340B program is driving up taxpayer costs
Patient Daily | Sep 15, 2025

Physician assistant on sinus issues and sleep disruption: ‘Any kind of sinus issue will always affect your sleep’